Close Menu

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded a Yale University researcher a four-year, $3 million grant to investigate the molecular networks that underlie the histological features of idiopathic pulmonary fibrosis (IPF), with the goal of better understanding the disease and eventually developing therapeutic interventions.

IPF is a progressive disease characterized by scarring of lung tissue, which hinders the lung's ability to transport oxygen. It has no known cause and the only available treatment is lung transplantation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.